| Name | DPA-714 |
|---|---|
| Synonyms |
Pyrazolo[1,5-a]pyrimidine-3-acetamide, N,N-diethyl-2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethyl-
DPA-714 N,N-Diethyl-2-{2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl}acetamide Y1H4D2VKZD |
| Description | DPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM), which is designed with a fluorine atom in its structure, allowing labelling with fluorine -18 and in vivo imaging using positron emission tomography. [18F]DPA-714 successfully evaluates for the specific imaging of inflammation in various models of neuroinflammation and in a brain tumor model[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 7 nM (TSPO)[1] |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H27FN4O2 |
| Molecular Weight | 398.474 |
| Exact Mass | 398.211792 |
| LogP | 2.86 |
| Index of Refraction | 1.581 |